-
Real-world Outcomes in Multiple Myeloma
Study shines a light on the differences in outcomes between clinical trial patients with multiple myeloma and those receiving cancer treatment in their community.
by Sandra Gordon
-
January 26: The Week in Cancer News
Questions about screening for women with dense breast tissue, and the FDA asks drugmakers to add a warning to labels for CAR T-cell therapies.
by Thomas Celona
-
Some Breast Cancer Patients May Safely Skip Radiation
Three presentations at SABCS in December find that it may be safe in certain cases for people with breast cancer to go without radiation.
by Cancer Research Catalyst
-
January 19: The Week in Cancer News
Preventive gastrectomy has lasting effects, and rising cancer incidence undercuts continued progress against mortality.
by Eric Fitzsimmons
-
January 12: The Week in Cancer News
Hiding serious illness can be a coping strategy, and cancer rates are on the rise among young people.
by Kevin McLaughlin
-
Doctors Urge Need for ‘Common Sense Oncology’
A movement of health care professionals say the toll of many cancer treatments is out of sync with the purported benefits.
by Kyle Bagenstose
-
January 5: The Week in Cancer News
The FDA will review a blood test that detects colon cancer, and a writer recounts his sister’s decision to receive medical aid in dying.
by Marci A. Landsmann
Cancer Talk
Physical Activity Linked to Lower Colon Cancer Recurrence
Participating in a structured exercise program after treatment was associated with a reduced risk of recurrence in people who had colon cancer.
by Sandra Gordon
Gaps in Survivorship Care Leave Unmet Needs After Cancer TreatmentA survey of head and neck cancer survivors reveals that many are not getting adequate survivorship care and may not even know it is available.
by Cameron Walker
Improving Communication for Deaf Cancer PatientsAfter a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.
by Eric Fitzsimmons
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose